Solid-State Overview of R-Baclofen: Relative Stability of Forms A, B and C and Characterization of a New Heterosolvate

J Pharm Sci. 2021 Oct;110(10):3457-3463. doi: 10.1016/j.xphs.2021.06.018. Epub 2021 Jun 12.

Abstract

A new polymorphic form (Form C) of enantiopure Baclofen was isolated and characterized. Crystal structures of R-Baclofen Form A and Form C were resolved from powder diffraction data, and cell parameters by profile matching for Form B. The relative stability of these three forms is proposed based on structural data, thermal analyses and solvent-mediated conversions. The experiments highlight the stability order A < C < B at 25 °C (A is the most stable form), whereas above 180 °C it would likely be: C < A < B (C being the stable modification). Moreover, a new heterosolvate of the molecule is observed in N,N-DMF/water mixture. This heterosolvate offers a new pathway to isolate pure R-Baclofen Form B provided the lactam impurity does not exceed 3%. Upon mechanical stress Form B tends to evolve to Form C.

Keywords: Arbaclofen/ R-baclofen; Crystallization; Desolvation; Phase diagram(s); Polymorphs; SOLID-state stability; Solvate(s).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Baclofen*
  • Calorimetry, Differential Scanning
  • Crystallization
  • Powder Diffraction
  • X-Ray Diffraction

Substances

  • Baclofen